• Ono Pharmaceutical average return on tangible equity for 2023 was 17.59, a 6.87% increase from 2022.
• Ono Pharmaceutical average return on tangible equity for 2022 was 16.46, a 11.07% increase from 2021.
• Ono Pharmaceutical average return on tangible equity for 2021 was 14.82, a 12.1% increase from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.